Regeneron Pharmaceuticals (REGN) Current Leases (2010 - 2026)
Regeneron Pharmaceuticals' (REGN) quarterly Current Leases came in at $720.0 million in Q1 2026, little changed quarter-over-quarter from $719.7 million in Q4 2021.
Regeneron Pharmaceuticals (REGN) Current Leases (2010 - 2026) Analysis & Trends
Regeneron Pharmaceuticals' Current Leases history runs 8 years deep, the most recent figure standing at $720.0 million for Q1 2026.
- On a quarterly basis, Current Leases changed N/A year-over-year to $720.0 million in Q1 2026; TTM through Mar 2026 was $720.0 million, a N/A change from a year earlier, with the FY2021 full-year figure at $719.7 million, changed N/A from the prior year.
- Current Leases held at $720.0 million in Q1 2026 per REGN's latest filing, from $719.7 million in the prior quarter.
- Across five years, Current Leases topped out at $720.0 million in Q1 2026 and bottomed at $720.0 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.61 Mn |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 45.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 720.00 Mn |
| Dec 31, 2021 | 719.70 Mn |
| Sep 30, 2021 | 719.00 Mn |
| Jun 30, 2021 | 718.40 Mn |
| Mar 31, 2021 | 717.80 Mn |
| Dec 31, 2016 | 127.27 Mn |
| Sep 30, 2014 | 1.25 Mn |
| Jun 30, 2014 | 1.06 Mn |
| Mar 31, 2014 | 1.06 Mn |
| Dec 31, 2013 | 939,000.00 |
| Sep 30, 2013 | 794,000.00 |
| Jun 30, 2013 | 794,000.00 |
| Mar 31, 2013 | 1.47 Mn |
| Dec 31, 2012 | 1.37 Mn |
| Sep 30, 2012 | 1.28 Mn |
| Jun 30, 2012 | 1.18 Mn |
| Mar 31, 2012 | 1.09 Mn |
| Dec 31, 2011 | 1.01 Mn |
| Dec 31, 2010 | 675,000.00 |